DMAA
NASDAQ · N/A
Drugs Made In America Acquis
$10.71
+0.01 (+0.05%)
Open$10.70
Previous Close$10.71
Day High$10.72
Day Low$10.69
52W High$10.72
52W Low$10.22
Volume—
Avg Volume29.6K
Market Cap259.88M
P/E Ratio39.04
EPS$0.22
SectorN/A
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 219.69M | 205.61M | 216.54M |
| Net Income | 25.03M | 23.39M | 21.58M |
| Profit Margin | 11.4% | 11.4% | 10.0% |
| EBITDA | 37.03M | 38.19M | 42.37M |
| Free Cash Flow | 19.51M | 14.22M | 14.32M |
| Rev Growth | -5.7% | -2.0% | +21.2% |
| Debt/Equity | 0.87 | 0.86 | 1.14 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $3.02 | +8.24% | — | 1.41B |
| PICS | Pics Nv | $10.27 | +0.49% | 6.6 | 1.48B |
| DMII | Drugs Made In America Acquis | $10.12 | -0.10% | 75.2 | 645.28M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.73 | -0.05% | 35.5 | 336.67M |
| CEPF | Cantor Equity Partners-Cl A | $10.40 | +0.48% | 57.9 | 595.50M |